Search research articles
Contact Us
Filters
Showing results (1-10 of 99) with videos related to
Page
of 10
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 9, 2022
Risk of Variceal Bleeding in Patients With Advanced Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab
Yeonjung Ha, Jee Hyun Kim, Jaekyung Cheon, et al.
Therapeutic Advances in Medical Oncology
|
April 2, 2021
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
October 7, 2020
"Teachable Moment": Effects of an Educational Program on Knowledge and Quality of Life of Korean Breast Cancer Survivors
Jaekyung Cheon, Yunsuk Choi, Jin Sung Kim, et al.
Journal of Cancer
|
May 8, 2023
High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma
Youngun Kim, Hannah Yang, Won Suk Lee, et al.
Anticancer Research
|
December 8, 2019
Clinical Implications of Claudin18.2 Expression in Patients With Gastric Cancer
Jin Ho Baek, Dong Jin Park, Gyu Yeol Kim, et al.
Journal of Cancer Research and Clinical Oncology
|
January 28, 2025
Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan
Jaekyung Cheon, Shigeo Shimose, Hyung-Don Kim, et al.
Cancer Research and Treatment
|
November 11, 2014
Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation
Yumun Jeong, Jaekyung Cheon, Tae-Oh Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 7, 2022
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab
Kyunghye Bang, Jaekyung Cheon, Young Soo Park, et al.
Cancer Medicine
|
August 23, 2022
Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
Young Eun Chon, Jaekyung Cheon, Hyeyeong Kim, et al.
Cancers
|
April 12, 2022
Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 99) with videos related to
Sort By:
Page
of 10
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 9, 2022
Risk of Variceal Bleeding in Patients With Advanced Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab
Yeonjung Ha, Jee Hyun Kim, Jaekyung Cheon, et al.
Therapeutic Advances in Medical Oncology
|
April 2, 2021
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
Kyunghye Bang, Jaekyung Cheon, Jae Ho Jeong, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
October 7, 2020
"Teachable Moment": Effects of an Educational Program on Knowledge and Quality of Life of Korean Breast Cancer Survivors
Jaekyung Cheon, Yunsuk Choi, Jin Sung Kim, et al.
Journal of Cancer
|
May 8, 2023
High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma
Youngun Kim, Hannah Yang, Won Suk Lee, et al.
Anticancer Research
|
December 8, 2019
Clinical Implications of Claudin18.2 Expression in Patients With Gastric Cancer
Jin Ho Baek, Dong Jin Park, Gyu Yeol Kim, et al.
Journal of Cancer Research and Clinical Oncology
|
January 28, 2025
Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan
Jaekyung Cheon, Shigeo Shimose, Hyung-Don Kim, et al.
Cancer Research and Treatment
|
November 11, 2014
Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation
Yumun Jeong, Jaekyung Cheon, Tae-Oh Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
May 7, 2022
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab
Kyunghye Bang, Jaekyung Cheon, Young Soo Park, et al.
Cancer Medicine
|
August 23, 2022
Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
Young Eun Chon, Jaekyung Cheon, Hyeyeong Kim, et al.
Cancers
|
April 12, 2022
Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, et al.
Page
of 10